Higher expression of CDK5 was found in lung cancer patients with lymphatic metastasis (76.6 %, 98/128) compared to those without lymphatic metastasis (37.6 %, 88/234, P < 0.001, Table 3). Here, CDK5 is linked to lung carcinoma.